Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity.

Source:http://linkedlifedata.com/resource/pubmed/id/21499110

Download in:

View as

General Info

PMID
21499110